Breast Cancer Clinical Trial
Official title:
Teleconference Group: Breast Cancer in African Americans
African American women with breast cancer have decreased quality of life (and mood when compared to European American. Research has not examined the effectiveness of therapeutic group for African American women with breast cancer even though positive effects are well established for Caucasians. The aims of the randomized clinical trial are to determine the effectiveness of TG by teleconference for African American women with breast cancer and what factors may impact on the intervention. The primary hypothesis is that participants in the intervention group will have significantly greater cancer knowledge, less fear, less isolation, better social connection, better mood, and better QOL when compared to a control group receiving usual psychosocial care. Two hundred forty African American women with breast cancer will be recruited. Intervention participants attend eight weekly 90 minute sessions by teleconference and two follow-up boosters. Each culturally appropriate session contains the story, information and group processes of connection, commonality and catharsis. Information focuses on increasing self care and stress management knowledge while countering myths and taboos. Story capitalizes on African American oral traditions by discussing coping parables. Group processes provide an alternative source of social support and opportunities to express feelings. Control group subjects receive standard psychosocial care (the use of any support programs or services locally or nationally. Testing will occur at baseline, after 10 group sessions and 16 weeks post baseline. The study findings are expected to inform about the effectiveness of therapeutic groups in African American women with breast cancer and lay the groundwork for exploring if reducing disparities in psychosocial care have a health benefit.
A. Specific Aims Aim One The major aim of the proposed study is to compare the effects of a
TG by conference call for AAWBC with usual psychosocial care. We hypothesize that AAWBC who
receive the TG by teleconference will have significantly greater cancer knowledge, less fear,
less isolation, better social connection, better mood, and better QOL than a control group
receiving usual psychosocial care.
Aim One A: Substantiate intervention integrity (purity, dosage, specificity and
interventionist competency) of first 14 waves of study.
Aim One B: Establish reliability and validity of measures (Profile of Mood States and
Functional Assessment of Cancer Therapy - Breast Cancer Version, Social Support
Questionnaire) Aim Two To have a strong intervention, it is essential to identify the
processes of change that lead to beneficial outcomes.29, 30 Therefore, the second aim of the
proposed study is to identify the mediators of the intervention that predict successful
treatment outcomes.
Aim Three Since it is particularly important to identify AA women's characteristics and
sociocultural factors which may affect their responses to the intervention,30, 31 the third
aim of the study is to identify the effects of demographic, health and socio-cultural
variables as moderators of treatment effects on social connection, and QOL.
Aim Three A: Examine baseline moderators and concept of social connection to establish
associations.
C. EXPERIMENTAL DESIGN & METHODS Design The proposed study will be conducted as a
multiple-group randomized trial to compare the TG intervention with a control group receiving
usual psychosocial care. A maximum of 10 subjects will be assigned randomly to each of two
groups during a common time period, with one group receiving the TG intervention and the
other receiving usual care. The randomization will be stratified by treatment type (chemo
therapy only or radiation therapy only or chemotherapy and radiation therapy combined).
Multiple time periods will be used to achieve the required number of subjects for the entire
trial. Subjects will be evaluated at three time points in a repeated measures fashion: (1) at
baseline before the intervention begins, (2) at the end of the intervention period, and (3)
16 weeks from baseline. Mediating, moderating and outcome variable data will be collected at
all three time periods.
These measurement times have been chosen for several reasons. The intervention will be
delivered during the stressful time after diagnosis when the patient is facing fears, side
effects (especially body image changes), and negative community attitudes. During this time,
patients are challenged to learn about the disease and its treatment and are emotionally open
to using positive coping strategies.133-136 The T-2 measurement will provide information on
the immediate effects of the treatment and T-3 will provide information on the sustainability
of the intervention effects.
Setting South Carolina is an ideal setting within which to test the proposed intervention, TG
by teleconference. AA represent about 31 % of the population. Unlike other parts of the US,
SC is mostly rural (and 46 % of its AA are rural) and the AA population has experienced very
little in-migration over the past several centuries.137 Furthermore, religious affiliation is
largely fundamentalist Christian (African Methodist Episcopal, Baptist and Pentecostal
Churches),138 and a spiritual focus permeates the community, which is known as the "Buckle"
of the Bible Belt.
Major statewide initiatives to decrease health disparities are in progress and these efforts
have resulted in multiple networks for communication with key SC community leaders and health
providers. We will use the Cancer Research Network, SC Cancer Alliance, Women's Cancer
Coalition and the Best Chance Network to enhance recruitment efforts.
Palmetto Health and the University of South Carolina are exceptional bases from which to
conduct this research. Palmetto Health is South Carolina's most comprehensive health
resource, a locally owned, not-for-profit healthcare system with Palmetto Health Baptist
Easley in upstate SC and two Columbia hospitals, Palmetto Health Baptist and Palmetto Health
Richland. Palmetto Health's Comprehensive Breast Center (PHCBC) was established to improve
treatment using national guidelines and decrease mortality. Over the past several years,
major strides have been made in attaining these goals through detection of smaller tumors and
use of sentinel node biopsy. Two multi-disciplinary and multi-specialty breast cancer tumor
conferences are held weekly. Additionally, Palmetto Health has made a strong commitment to
decrease health disparities in the communities it serves through its Cancer Community Health
Initiative. The 6 year-old initiative has targeted AAs and is working to improve individual
and community health by providing services to underserved and uninsured populations
especially cancer screening.
One of the oldest and most comprehensive public universities in the United States, USC has
been designated a research institution of "very high research activity," the only university
in South Carolina to have this designation, granted to 62 public and 32 private research
institutions. University libraries in Columbia house over 7,000,000 processed items including
2,639,171 volumes and approximately 4,075,413 units in microform. Some 17,405 current
periodicals are received. Thomas Cooper Library. Included in the seating are more than 900
private locked facilities for faculty and graduate students involved in research. Special
areas in the library include the Student Computer Labs, the Science Library, Special
Collections, and the Map Library. Access to the collection is obtained through the
USCAN/NOTIS Online Card Catalog with terminals located throughout the building. CD ROM
stations are available for user searching of multiple databases. The Thomas Cooper Library
offers access to literature from international sources through the on-line computer-assisted
reference department. The computerized reference service provides bibliographic citations,
statistics, and international news from recent literature on a wide range of subjects. This
service is particularly strong in the natural and social sciences. Also included are
government activities, publications, and grant sources. Data bases in nursing include
Medline, Nursing and Allied Health, and Health Planning and Administration. Data bases
related to nursing include Psychological Abstracts and Mental Health Abstracts. New data
bases are added regularly, and information on them is available in the Reference Department.
The majority of participants in the proposed study will be recruited from the two cancer
treatment sites within Palmetto Health, which treats about 600 breast cancer patients
annually. Of those, more than 225 are AAWBC. Other recruitment will be statewide.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |